Advertisement
Advertisement
NYXH
Nyxoah SA Ordinary Shares
0.85
USDSponsored
+0.03
+4.27%
Nov 06, 15:59 UTC -5
Closed
After-Market
1.06
+0.21
+24.88%
Nyxoah SA Ordinary Shares (NYXH) Earnings
NYXH Earnings Reports
Positive Surprise Ratio
NYXH beat 11 of 22 last estimates.
50%
Next Report
Date of Next Report
Mar 17, 2027
Estimate for Q4 26 (Revenue/ EPS)
$13.90M
/-$0.16
Implied change from Q3 26 (Revenue/ EPS)
+48.02%
/-5.88%
Implied change from Q4 25 (Revenue/ EPS)
+146.35%
/-72.41%
Nyxoah SA Ordinary Shares earnings per share and revenue
On Nov 05, 2026, NYXH reported earnings of -0.17 USD per share (EPS) for Q3 26, beating the estimate of -0.30 USD, resulting in a 42.29% surprise. Revenue reached 9.39 million, compared to an expected 10.14 million, with a -7.37% difference. The market reacted with a +4.27% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -0.16 USD, with revenue projected to reach 13.90 million USD, implying an decrease of -5.88% EPS, and increase of 48.02% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.78
Actual
$0.88
Surprise
+12.07%
Evolent Health, Inc Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.05
Actual
$0.06
Surprise
+13.21%
Fulgent Genetics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.66
Actual
-$0.09
Surprise
+86.43%
Health Catalyst, Inc Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.03
Surprise
+38.14%
CareCloud, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.11
Actual
$0.14
Surprise
+19.35%
10x Genomics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.15
Surprise
+43.35%
Doximity, Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$0.35
Actual
$0.36
Surprise
+0.56%
iRhythm Holdings, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.06
Actual
$0.82
Surprise
+1,214.10%
Privia Health Group, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.10
Surprise
+3.73%
Schrodinger, Inc. Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.70
Actual
-$0.50
Surprise
+29.57%
FAQ
What were Nyxoah SA Ordinary Shares's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Nyxoah SA Ordinary Shares reported EPS of -$0.17, beating estimates by 42.29%, and revenue of $9.39M, -7.37% below expectations.
How did the market react to Nyxoah SA Ordinary Shares's Q3 2026 earnings?
The stock price moved up 4.27%, changed from $0.81 before the earnings release to $0.85 the day after.
When is Nyxoah SA Ordinary Shares expected to report next?
The next earning report is scheduled for Mar 17, 2027.
What are the forecasts for Nyxoah SA Ordinary Shares's next earnings report?
Based on --
analysts, Nyxoah SA Ordinary Shares is expected to report EPS of -$0.16 and revenue of $13.90M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.